Literature DB >> 27416565

Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies.

Erwin Strobel1,2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27416565      PMCID： PMC5448834          DOI： 10.2450/2016.0302-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  11 in total

1.  Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4)

Authors:  O Meyer; A Salama; N Pittet; P Schwind
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

2.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Authors:  G K Lo; D Juhl; T E Warkentin; C S Sigouin; P Eichler; A Greinacher
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

3.  The biological basis of immune heparin-induced thrombocytopenia.

Authors:  J Amiral; A Marfaing-Koka; M Poncz; D Meyer
Journal:  Platelets       Date:  1998       Impact factor: 3.862

4.  The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays.

Authors:  Petra Eichler; Ricarda Raschke; Norbert Lubenow; Oliver Meyer; Peter Schwind; Andreas Greinacher
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

5.  Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay.

Authors:  Karina Althaus; Ulrike Strobel; Theodore E Warkentin; Andreas Greinacher
Journal:  Thromb Res       Date:  2011-05-28       Impact factor: 3.944

6.  Bilateral lower extremity gangrene requiring amputation associated with heparin-induced thrombocytopenia--a case report.

Authors:  Brian P Dickinson; Daniel A De Ugarte; Todd D Reil; Bryce D Beseth; Peter F Lawrence
Journal:  Vasc Endovascular Surg       Date:  2006 Mar-Apr       Impact factor: 1.089

7.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Authors:  Nadine Martel; James Lee; Philip S Wells
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

Review 8.  Heparin-induced thrombocytopenia.

Authors:  A Greinacher; K Althaus; K Krauel; S Selleng
Journal:  Hamostaseologie       Date:  2010-01       Impact factor: 1.778

9.  Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis.

Authors:  Tamam Bakchoul; Heike Zöllner; Jean Amiral; Simon Panzer; Sixten Selleng; Thomas Kohlmann; Sven Brandt; Mihaela Delcea; Theodore E Warkentin; Ulrich J Sachs; Andreas Greinacher
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

10.  Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.

Authors:  A Greinacher; D Juhl; U Strobel; A Wessel; N Lubenow; K Selleng; P Eichler; T E Warkentin
Journal:  J Thromb Haemost       Date:  2007-05-07       Impact factor: 5.824
View more
  1 in total

1.  A Rare Case of Superior Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2.

Authors:  Irina Panovska-Stavridis; Aleksandra Pivkova-Veljanovska; Sanja Trajkova; Menka Lazarevska; Aleksandra Grozdanova; Venko Filipche
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-03-01       Impact factor: 2.576
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.